Related Experiment Video
Updated: Sep 5, 2025

07:51
Development and Functionalization of Electrolyte-Gated Graphene Field-Effect Transistor for Biomarker Detection
Published on: February 1, 2022
3.4K
A SARS-Cov-2 sensor based on upconversion nanoparticles and graphene oxide.
Konstantina Alexaki1, Maria Eleni Kyriazi2, Joshua Greening1
1School of Physics and Astronomy, Faculty of Engineering and Physical Sciences, University of Southampton Southampton SO17 1BJ UK a.kanaras@soton.ac.uk.
RSC Advances
|July 8, 2022
Summary
This study presents a rapid diagnostic method for SARS-CoV-2 detection using oligonucleotide-coated nanoparticles and graphene oxide. The novel approach bypasses the need for polymerase chain reaction (PCR) amplification, enabling quick results.
Area of Science:
- Biomedical diagnostics
- Nanotechnology applications
- Molecular detection
Background:
- The COVID-19 pandemic highlighted the urgent need for rapid and accurate SARS-CoV-2 diagnostic tools.
- Traditional methods like PCR require amplification, increasing detection time.
Purpose of the Study:
- To develop a novel, rapid diagnostic method for SARS-CoV-2 detection.
- To demonstrate the efficacy of oligonucleotide-coated upconversion nanoparticles (UCNPs) and graphene oxide (GO) for viral detection.
Main Methods:
- Utilized oligonucleotide-functionalized upconversion nanoparticles (UCNPs).
- Integrated graphene oxide (GO) for enhanced detection capabilities.
- Targeted specific viral oligonucleotide markers without polymerase chain reaction (PCR) amplification.
Main Results:
- Achieved rapid detection of viral oligonucleotide markers.
- Demonstrated a viable alternative to PCR-based diagnostic methods.
- Successfully employed UCNPs and GO in a diagnostic assay.
Conclusions:
- Oligonucleotide-coated UCNPs and GO offer a promising platform for rapid SARS-CoV-2 diagnostics.
- This method significantly reduces detection time compared to conventional techniques.
- The developed assay provides a sensitive and efficient approach for identifying SARS-CoV-2 infection.

